Keith C. Regnante
2019
In 2019, Keith C. Regnante earned a total compensation of $1.1M as Former Chief Financial Officer at Wave Life Sciences Ltd., a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $108,675 |
|---|---|
| Salary | $362,250 |
| Stock Awards | $607,500 |
| Other | $9,642 |
| Total | $1,088,067 |
Regnante received $607.5K in stock awards, accounting for 56% of the total pay in 2019.
Regnante also received $108.7K in non-equity incentive plan, $362.3K in salary and $9.6K in other compensation.
Rankings
In 2019, Keith C. Regnante's compensation ranked 8,900th out of 13,971 executives tracked by ExecPay. In other words, Regnante earned more than 36.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,900 out of 13,971 | 36th |
Division Manufacturing | 3,552 out of 5,695 | 38th |
Major group Chemicals And Allied Products | 1,340 out of 2,194 | 39th |
Industry group Drugs | 1,141 out of 1,880 | 39th |
Industry Pharmaceutical Preparations | 844 out of 1,392 | 39th |
Source: SEC filing on June 26, 2020.
Regnante's colleagues
We found four more compensation records of executives who worked with Keith C. Regnante at Wave Life Sciences Ltd. in 2019.